$ALNT

Winter Michael R sold $50K of ALNT

Winter Michael R sold 457 shares of ALLIENT INC (ALNT) at $109.27 on 2026-09-23.

Original reporting
SEC EDGAR · Winter Michael R
Published Sep 23, 2026, 9:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALNT
Neutral
high confidence
Mentioned
$ALNT
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALNTNeutralLow
01

Why it matters

The sale is routine and unlikely to move the stock.

02

Market read

Limited relevance; primarily of interest to insiders and compliance monitors.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed in the filing.

Relevance 3/10Novelty 3/10Timing: today

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$ALNTNeutralHigh confidence
Context

Director Winter Michael R sold 457 shares for $49,936, reducing his holding to 39,154 shares.

Expected impact

minimal effect on stock price

Evidence & confidence

The transaction size is modest relative to float and does not signal a material change in insider confidence.

Market effects

None; the sale is company‑specific and does not affect the broader sector.

None; the filing is US‑based and limited to Allient Inc.

None; no global market effect.

Counterpoint

Some traders may view any insider sale as a bearish signal, but the size is too small to warrant a position change.

Key entities

  • Allient Inc

    US‑listed biotech firm (NASDAQ: ALNT).

  • Winter Michael R

    Director of Allient Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALNTMed

Why Allient (ALNT) Stock Is Down Today

Allient (ALNT) stock fell 4% after JPMorgan downgraded it from Overweight to Neutral, citing a 90% rally since May and an EV/EBITDA of 25.7. Analyst Tomohiko Sano raised Q3 and Q4 forecasts but set a $120 price target. Shares later recovered to $104.02, down 2.2%. The stock is up 87.1% YTD but 12.3% below its 52-week high.

$AEISMed

Electronic Components Stocks Q2 Results: Benchmarking Advanced Energy (NASDAQ:AEIS)

Eight electronic components stocks reported Q2 revenues 3.3% above estimates, with next quarter's guidance 6.9% higher. Despite strong results, shares fell 7.2% on average. Advanced Energy (AEIS) saw $574.1M revenue (up 30% YoY, 5.6% beat), but its stock dropped 10%. Allient (ALNT) and Littelfuse (LFUS) also beat estimates, while nLIGHT (LASR) missed EBITDA guidance, falling 46.4%.

$ALNTHighAI 8/10

Q2 Electronic Components Earnings: Allient (NASDAQ:ALNT) Impresses

Allient (ALNT) reported Q2 revenue of $153.8M, up 10.2% YoY, beating estimates by 5.5%. The company's stock is flat since reporting. Advanced Energy (AEIS) saw 30% YoY revenue growth, outperforming expectations by 5.6%, but its stock fell 6.1%. nLIGHT (LASR) reported 33.8% YoY revenue growth, beating estimates by 4.6%, but its stock dropped 44%. Belden (BDC) reported 11.6% YoY revenue growth, in line with expectations, and its stock rose 12.5%. Bel Fuse (BELF.A) saw 25.2% YoY revenue growth, bea

$ALNTMed

The Bull Case For Allient (ALNT) Could Change Following Its Zacks Rank Upgrade And Earnings Boost

Allient Inc. (ALNT) was upgraded to Zacks Rank #1 (Strong Buy) after its consensus earnings estimate rose 10.5% in 60 days, driven by strong Q2 2026 results. Analysts are optimistic about its precision motion and power solutions business, despite industry weakness. The company projects $671.5M revenue and $48.7M earnings by 2029, requiring 6.2% annual revenue growth.